These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 30539901)
41. Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Douaud G; Filippini N; Knight S; Talbot K; Turner MR Brain; 2011 Dec; 134(Pt 12):3470-9. PubMed ID: 22075069 [TBL] [Abstract][Full Text] [Related]
42. Differential involvement of corticospinal tract (CST) fibers in UMN-predominant ALS patients with or without CST hyperintensity: A diffusion tensor tractography study. Rajagopalan V; Pioro EP Neuroimage Clin; 2017; 14():574-579. PubMed ID: 28337412 [TBL] [Abstract][Full Text] [Related]
43. White matter volume loss in amyotrophic lateral sclerosis: A meta-analysis of voxel-based morphometry studies. Chen G; Zhou B; Zhu H; Kuang W; Bi F; Ai H; Gu Z; Huang X; Lui S; Gong Q Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():110-117. PubMed ID: 29330136 [TBL] [Abstract][Full Text] [Related]
44. Alterations of spontaneous brain activity in systematic lupus erythematosus patients without neuropsychiatric symptoms: A resting-functional MRI study. Piao S; Wang R; Qin H; Hu B; Du J; Wu H; Geng D Lupus; 2021 Oct; 30(11):1781-1789. PubMed ID: 34620007 [TBL] [Abstract][Full Text] [Related]
45. Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis. Spinelli EG; Riva N; Rancoita PMV; Schito P; Doretti A; Poletti B; Di Serio C; Silani V; Filippi M; Agosta F Neuroimage Clin; 2020; 27():102315. PubMed ID: 32593977 [TBL] [Abstract][Full Text] [Related]
46. Disruption of the white matter structural network and its correlation with baseline progression rate in patients with sporadic amyotrophic lateral sclerosis. Li W; Wei Q; Hou Y; Lei D; Ai Y; Qin K; Yang J; Kemp GJ; Shang H; Gong Q Transl Neurodegener; 2021 Sep; 10(1):35. PubMed ID: 34511130 [TBL] [Abstract][Full Text] [Related]
47. Microstructural changes across different clinical milestones of disease in amyotrophic lateral sclerosis. Trojsi F; Caiazzo G; Corbo D; Piccirillo G; Cristillo V; Femiano C; Ferrantino T; Cirillo M; Monsurrò MR; Esposito F; Tedeschi G PLoS One; 2015; 10(3):e0119045. PubMed ID: 25793718 [TBL] [Abstract][Full Text] [Related]
58. Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. Schuster C; Hardiman O; Bede P BMC Neurol; 2017 Apr; 17(1):73. PubMed ID: 28412941 [TBL] [Abstract][Full Text] [Related]
59. Executive deficits, not processing speed relates to abnormalities in distinct prefrontal tracts in amyotrophic lateral sclerosis. Pettit LD; Bastin ME; Smith C; Bak TH; Gillingwater TH; Abrahams S Brain; 2013 Nov; 136(Pt 11):3290-304. PubMed ID: 24056536 [TBL] [Abstract][Full Text] [Related]
60. A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Chang JL; Lomen-Hoerth C; Murphy J; Henry RG; Kramer JH; Miller BL; Gorno-Tempini ML Neurology; 2005 Jul; 65(1):75-80. PubMed ID: 16009889 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]